A Review of Evidence-Based Medicine for Glucosamine and Chondroitin Sulfate Use in Knee Osteoarthritis

Arthroscopy - Journal of Arthroscopic and Related Surgery

Volumn 25, Issue 1, 2009, Pages 86-94

  Vangsness Jr , C Thomas ^a   Spiker, William ^a   Erickson, Juliana ^a  

^a UNIVERSITY OF SOUTHERN CALIFORNIA   (United States)

Author keywords

Chondroitin sulfate; Glucosamine hydrochloride; Glucosamine sulfate; Knee osteoarthritis; Nutritional supplement

Indexed keywords

CELECOXIB; CHONDROITIN SULFATE; CYCLOOXYGENASE 2 INHIBITOR; DICLOFENAC; DIMETHYL SULFONE; GLUCOSAMINE; GLUCOSAMINE SULFATE; IBUPROFEN; NONSTEROID ANTIINFLAMMATORY AGENT; OPIATE; PARACETAMOL; PLACEBO; S ADENOSYLMETHIONINE;

ARTHRALGIA; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; DISEASE SEVERITY; DRUG DOSE COMPARISON; DRUG EFFICACY; DRUG SAFETY; EVIDENCE BASED MEDICINE; GASTROINTESTINAL SYMPTOM; HUMAN; JOINT FUNCTION; JOINT RADIOGRAPHY; KINESIOTHERAPY; KNEE OSTEOARTHRITIS; RANDOMIZED CONTROLLED TRIAL; REVIEW; TREATMENT OUTCOME; UNSPECIFIED SIDE EFFECT;

CHONDROITIN SULFATES; DIETARY SUPPLEMENTS; EVIDENCE-BASED MEDICINE; GLUCOSAMINE; HUMANS; OSTEOARTHRITIS, KNEE; TREATMENT OUTCOME;

EID: 57849089074     PISSN: 07498063     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.arthro.2008.07.020     Document Type: Review

References (55)

1. Adachi N., Ochi M., Deie M., Ito Y., and Izuta Y. Lateral compartment osteoarthritis of the knee after meniscectomy treated by the transplantation of tissue-engineered cartilage and osteochondral plug. Arthroscopy 22 (2006) 107-112
2. Spahn G., Mückley T., Kahl E., and Hofmann G.O. Factors affecting the outcome of arthroscopy in medial-compartment osteoarthritis of the knee. Arthroscopy 22 (2006) 1233-1240
3. Ikeuchi M., Takahashi T., and Tani T. Localized synovial hypertrophy in the anteromedial compartment of the osteoarthritic knee. Arthroscopy 21 (2005) 1457-1461
4. Bae D.K., Yoon K.H., and Song S.J. Cartilage healing after microfracture in osteoarthritic knees. Arthroscopy 22 (2006) 367-374
5. Stuart M.J., and Lubowitz J.H. What, if any, are the indications for arthroscopic debridement of the osteoarthritic knee?. Arthroscopy 22 (2006) 238-239
6. US Senate Committee on Health, Education, Labor and Pensions, Subcommittee on Aging. Center for Disease Control's role in combating the burden of arthritis (2004), Department of Health & Human Services, Washington, DC
7. Fries J.F., Williams C.A., Block D.A., and Michel B.A. Nonsteroidal anti-inflammatory drug-associated gastropathy: Incidence and risk factor models. Am J Med 91 (1991) 213-222
8. Deeks J.J., Smith L.A., and Bradley M.D. Efficacy, tolerability, and upper gastrointestinal safety of celecoxib for treatment of osteoarthritis and rheumatoid arthritis: Systematic review of randomised controlled trials. BMJ 325 (2002) 619
9. Vetter G. Topical therapy of arthroses with glucosamine (Dona 200). Munch Med Wochenschr 11 (1969) 1499-1502 (in German)
10. Theodasksi J., Adderly B., and Fox B. The arthritis cure (1997), St Martin's, New York, NY
11. Bucsi L., and Poór G. Efficacy and tolerability of oral chondroitin sulfate as a symptomatic slow-acting drug for osteoarthritis (SYSADOA) in the treatment of knee osteoarthritis. Osteoarthritis Cartilage 6 suppl A (1998) 31-36
12. Bourgeois P., Chales G., Dehais J., Delcambre B., Kuntz J.L., and Rozenberg S. Efficacy and tolerability of chondroitin sulfate 1200 mg/day vs chondroitin sulfate 3 × 400 mg/day vs placebo. Osteoarthritis Cartilage 6 (1998) 25-30
13. Conrozier T. Anti-arthrosis treatments: Efficacy and tolerance of chondroitin sulfates (CS 4&6). Presse Med 27 (1998) 1862-1865 (in French)
14. Mazieres B., Combe B., Phan Van A., Tondut J., and Grynfeltt M. Chondroitin sulfate in osteoarthritis of the knee: A prospective, double blind, placebo controlled multicenter clinical study. J Rheumatol 28 (2001) 173-181
15. Mazieres B., Hucher M., Zaim M., and Garnero P. Effect of chondroitin sulfate in symptomatic knee osteoarthritis: A multicentre, randomised, double-blind, placebo-controlled study. Ann Rheum Dis 66 (2007) 639-645
16. Uebelhart D., Malaise M., Marcolongo R., et al. Intermittent treatment of knee osteoarthritis with oral chondroitin sulfate: A one year, randomized, double-blind, multicenter study versus placebo. Osteoarthritis Cartilage 12 (2004) 269-276
17. Mathieu P. Radiological progression of internal femoro-tibial osteoarthritis in gonarthrosis. Chondro-protective effect of chondroitin sulfates ACS4-ACS6. Presse Med 31 (2002) 1386-1390 (in French)
18. Michel B.A., Stucki G., Frey D., et al. Chondroitins 4 and 6 sulfate in osteoarthritis of the knee: A randomized, controlled trial. Arthritis Rheum 52 (2005) 779-786
19. Rothenfluh D.A., Reedwisch D., Müller U., Ganz R., Tennant A., Leunig M., et al. Construct validity of a 12-item WOMAC for assessment of femoro-acetabular impingement and osteoarthritis of the hip. Osteoarthritis Cartilage 16 (2008) 1032-1038
20. Noack W., Fischer M., Förster K.K., Rovati L.C., and Setnikar I. Glucosamine sulfate in osteoarthritis of the knee. Osteoarthritis Cartilage 2 (1994) 51-59
21. Reichelt A., Forster K.K., Fischer M., Rovati L.C., and Setnikar I. Efficacy and safety of intramuscular glucosamine sulfate in osteoarthritis of the knee. A randomised, placebo controlled, double-blind study. Arzneimittelforschung 44 (1994) 75-80
22. Reginster J.Y., Derolsy R., Rovati L.C., et al. Long-term effects of glucosamine sulfate on osteoarthritis progression: A randomized, placebo-controlled clinical trial. Lancet 357 (2001) 251-256
23. Pavelká K., Gatterová J., Olejarová M., et al. Glucosamine sulfate use and delay of progression of knee osteoarthritis. Arch Intern Med 162 (2002) 2113-2123
24. Bruyere O., Pavelka K., Rovati L.C., et al. Glucosamine sulfate reduces osteoarthritis progression in postmenopausal women with knee osteoarthritis: Evidence from two 3 year studies. Menopause 11 (2004) 138-143
25. Bruyere O., Honore A., Ethgen O., et al. Correlation between radiographic severity of knee osteoarthritis and future disease progression. Results from a 3-year prospective, placebo-controlled study evaluating the effect of glucosamine sulfate. Osteoarthritis Cartilage 11 (2003) 1-5
26. Cibere J., Kopec J.A., Thorne A., et al. Randomized, double-blind, placebo-controlled glucosamine discontinuation trial in knee osteoarthritis. Arthritis Rheum 51 (2004) 738-745
27. Herrero-Beaumont G., Ivorra J.A., Del Carmen Trabada M., et al. Glucosamine sulfate in the treatment of knee osteoarthritis symptoms: A randomized, double-blind, placebo-controlled study using acetaminophen as a side comparator. Arthritis Rheum 56 (2007) 555-567
28. Hughes R., and Carr A. A randomized, double-blind, placebo-controlled trial of glucosamine sulphate as an analgesic in osteoarthritis of the knee. Rheumatology (Oxford) 41 (2002) 279-284
29. Houpt J.B., McMillan R., Wein C., and Paget-Dellio S.D. Effect of glucosamine hydrochloride in the treatment of pain of osteoarthritis of the knee. J Rheumatol 26 (1999) 2423-2430
30. McAlindon T.E., Formica M., LaValley M., Lehmer M., and Kabbara K. Effectiveness of glucosamine for symptoms of knee osteoarthritis: Results from an internet-based randomized double-blind controlled trial. Am J Med 117 (2004) 643-649
31. Clegg D., Reda D.J., Harris C.L., et al. Glucosamine, chondroitin sulfate, and the two in combination for painful knee osteoarthritis. N Engl J Med 354 (2006) 795-808
32. Kaptchuk T.J. The placebo effect in alternative medicine: Can the performance of the healing ritual have clinical significance?. Ann Intern Med 136 (2002) 817-825
33. Alekseeva L.I., Chichasova N.V., Benevolenskaia L.I., Nasonov E.L., and Mendel' O.I. Combined medication ARTRA in the treatment of osteoarthrosis. Ter Arkh 77 (2005) 69-75 (in Russian)
34. Messier S.P., Mihalko S., Loeser R.F., et al. Glucosamine/chondroitin combined with exercise for the treatment of knee osteoarthritis: A preliminary study. Osteoarthritis Cartilage 15 (2007) 1256-1266
35. McAlindon T.E., LaValley M.P., Gulin J.P., et al. Glucosamine and chondroitin for treatment of osteoarthritis: A systematic quality assessment and meta-analysis. JAMA 283 (2000) 1469-1475
36. Richy F., Bruyere O., Ethgen O., Cucherat M., Henrotin Y., and Reginster J.Y. Structural and symptomatic efficacy of glucosamine and chondroitin in knee osteoarthritis: A comprehensive meta-analysis. Arch Intern Med 163 (2003) 1514-1522
37. Bjoral J.M., Kloving A., Ljunggren A.E., and Slordal L. Short-term efficacy of pharmacotherapeutic interventions in osteoarthritic knee pain: A meta-analysis of randomized placebo-controlled trials. Eur J Pain 11 (2007) 125-138
38. Distler J., and Angueloouch A. Evidence-based practice: Review of clinical evidence on the efficacy of glucosamine and chondroitin in the treatment of arthritis. J Am Acad Nurse Pract 18 (2006) 487-493
39. Reichenbach S., Sterchi R., Scherer M., et al. Meta-analysis: Chondroitin for osteoarthritis of the knee or hip. Ann Intern Med 146 (2007) 580-590
40. Leeb B.F., Schweitzer H., Montag K., and Smolen J.S. A metaanalysis of chondroitin sulfate in the treatment of osteoarthritis. J Rheumatol 27 (2000) 205-211
41. Towheed T.E., Maxwell L., Anastassiades T.P., et al. Glucosamine therapy for treating osteoarthritis. Cochrane Database Syst Rev (2005) CD002946
42. Konig B. A long-term (two year) clinical trial with S-adenosylmethionine of the treatment of osteoarthritis. Am J Med 83 (1987) 89-94
43. Muller-Fassbender H. Double-blind clinical trial multicenter study comparing S-adenosylmethionine, naproxen, and placebo in the treatment of osteoarthritis. Am J Med 83 (1987) 1-4
44. Maccagno A., Di Giorgio E.E., Caston O.L., and Sagasta C.L. Double-blinded controlled clinical trial of oral S-adenosylmethionine versus piroxicam in knee osteoarthritis. Am J Med 83 (1987) 72-77
45. Vetter G. Double-blind comparative clinical trial with S-adenosylmethionine and indomethacin in the treatment of osteoarthritis. Am J Med 83 (1987) 78-80
46. Najm W.I., Reinsch S., Hoehler F., Tobis J.S., and Harvey P.W. S-adenosylmethionine (SAMe) versus celecoxib for the treatment of osteoarthritis symptoms: A double-blind cross-over trial. BMC Musculoskelet Disord 5 (2004) 6
47. Jacob S.W., and Herschler R. Dimethyl sulfoxide after twenty years. Ann N Y Acad Sci 411 (1983) 13-17
48. Usha P.R., and Naida M.U.R. Randomised, double-blind, parallel, placebo-controlled study of oral glucosamine, methylsulfonylmethane and their combination in osteoarthritis. Clin Drug Invest 24 (2004) 353-363
49. Kim L.S., Axelrod L.J., Howard P., Buratovich N., and Waters R.F. Efficacy of methylsulfonylmethane (MSM) in osteoarthritis pain of the knee: A pilot clinical trial. Osteoarthritis Cartilage 14 (2006) 286-294
50. Owens S., Wagner P., and Vangsness Jr. C.T. Recent advances in glucosamine and chondroitin supplementation. J Knee Surg 17 (2004) 185-193
51. Bekelman J.E., Li Y., and Gross C.P. Scope and impact of financial conflicts of interest in biomedical research: A systematic review. JAMA 289 (2003) 454-465
52. Russell A.S., Aghazadeh-Habashi A., and Jamali F. Active ingredient consistency of commercially available glucosamine sulfate products. J Rheumatol 29 (2002) 2407-2409
53. Joint supplements: Brands to try and brands to avoid. Consumer Reports. June 2006.
54. Dickinson A. Docket No. 96N-0417, good manufacturing practices for dietary supplements. http://www.crnusa.org/pdfs/CRN_FDA_GMPS081103_Process.pdf Accessed March 2, 2007
55. Hathcock J.N., and Shao A. Risk assessment for glucosamine and chondroitin sulfate. Regul Toxicol Pharmacol 47 (2007) 78-83